Effects of adenovirus-mediated gene transfer of ICOSIg and CTLA4Ig fusion protein on experimental autoimmune myocarditis

References

• Hessel FP, Wegner C, Muller J, Glaveris C, Wasem J. Economic evaluation and survival analysis of immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Eur J Health Econ 2004; 5(1)58–63
   PubMedGoogle Scholar
• Kono K. Autoimmune myocarditis. Nippon Rinsho 2005; 63(5)512–515
   PubMedGoogle Scholar
• Afanasyeva M, Georgakopoulos D, Rose NR. Autoimmune myocarditis: Cellular mediators of cardiac dysfunction. Autoimmun Rev 2004; 3(7–8)476–486
   PubMed Web of Science ®Google Scholar
• Van Berkel ME, Schuijver EH, Hofhuis FM, Sharpe AH, Coyle AJ, Broeren CP, Tesselaar K, Oosterwegel MA. ICOS contributes to T cell expansion in ctla-4 deficient mice. J Immunol 2005; 175(1)182–188
   PubMedGoogle Scholar
• Khatlani TS, Ma Z, Okuda M, Inokuma H, Onishi T. Autoantibodies against T-Cell costimulatory molecules are produced in canine autoimmune diseases. J Immunother 2003; 26(1)12–20
   PubMedGoogle Scholar
• Nurieva RI. Regulation of immune and autoimmune responses by ICOS-B7h interaction. Clin Immunol 2005; 115(1)19–25
   PubMedGoogle Scholar
• Buckbinder L, Robinson RP. The glucocorticoid receptor: Molecular mechanism and new therapeutic opportunities. Curr Drug Targets Inflamm Allergy 2002; 1(2)127–136
   PubMedGoogle Scholar
• Litzinger MT, Su Y, Lei TC, Soukhareva N, Scott DW. Mechanisms of gene therapy for tolerance: B7 signaling is required for peptide-IgG gene-transferred tolerance induction. J Immunol 2005; 175(2)780–787
   PubMed Web of Science ®Google Scholar
• Chandraker A, Huurman V, Hallett K, Yuan X, Tector AJ, Park CH, Lu E, Zavazava N, Oaks M. CTLA-4 is important in maintaining long-term survival of cardiac allografts. Transplantation 2005; 79(8)897–903
   PubMedGoogle Scholar
• Zheng Y, Jost M, Gaughan JP, Class R, Coyle AJ, Monestier M. ICOS-B7 homologous protein interactions are necessary for mercury-induced autoimmunity. J Immunol 2005; 174(5)3117–3121
   PubMedGoogle Scholar
• Shibasaki F. Immune anergy in T cell signaling. Nippon Rinsho 2005; 63(4)407–413
   PubMedGoogle Scholar
• Khayyamian S, Hutloff A, Buchner K, Grafe M, Henn V, Kroczek RA, Mages HW. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc Natl Acad Sci USA 2002; 99(9)6198–6203
   PubMedGoogle Scholar
• Daikh DI, Wofsy D. Effects of anti-B7 monoclonal antibodies on humoral immune responses. J Autoimmun 1999; 12(2)101–108
   PubMedGoogle Scholar
• Kohyama M, Sugahara D, Sugiyama S, Yagita H, Okumura K, Hozumi N. Inducible costimulator-dependent IL-10 production by regulatory T cells specific for self-antigen. Proc Natl Acad Sci USA 2004; 101(12)4192–4197
   PubMedGoogle Scholar
• Padrid PA, Mathur M, Li X, Herrmann K, Qin Y, Catmamanchi A, Weinstock J, Ellliott D, Sperling AI, Bluestone JA. CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma. Am J Respir Cell Mol Biol 1998; 18(4)453–462
   PubMedGoogle Scholar
• Matsui Y, Inobe M, Okamoto H, Chiba S, Shimizu T, Kitabatake A, Uede T. Blockade of T cell costimulatory signals using adenovirus vectors prevents both the induction and the progression of experimental autoimmune myocarditis. J Mol Cell Cardiol 2002; 34(3)279–295
   PubMedGoogle Scholar
• Sperling MA. Aspects of the etiology, prediction, and prevention of insulin-dependent diabetes mellitus in childhood. Pediatr Clin North Am 1997; 44(2)269–284
   PubMedGoogle Scholar
• Sandor M, Sperling AI, Cook GA, Weinstock JV, Lynch RG, Bluestone JA. Two waves of gamma delta T cells expressing different V delta genes are recruited into schistosome-induced liver granulomas. J Immunol 1995; 155(1)275–284
   PubMedGoogle Scholar
• Dong C, Nurieva RI. Regulation of immune and autoimmune responses by ICOS. J Autoimmun 2003; 21(3)255–260
   PubMedGoogle Scholar
• Kashizuka H, Sho M, Nomi T, Ikeda N, Kuzumoto Y, Akashi S, Tsurui Y, Mizuno T, Kanehiro H, Yagita H, Nakajima Y, Sayegh MH. Role of the ICOS-B7h costimulatory pathway in the pathophysiology of chronic allograft rejection. Transplantation 2005; 79(9)1045–1050
   PubMedGoogle Scholar
• Harada H, Salama AD, Sho M, Izawa A, Sandner SE, Ito T, Akiba H, Yagita H, Sharpe AH, Freeman GJ, Sayegh MH. The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. J Clin Invest 2003; 112(2)234–243
   PubMed Web of Science ®Google Scholar
• Ozkaynak E, Gao W, Shemmeri N, Wang C, Gutierrez-Ramos JC, Amaral J, Qin S, Rottman JB, Coyle AJ, Hancock WW. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol 2001; 2(7)591–596
   PubMed Web of Science ®Google Scholar
• Vieira PL, Wassink L, Smith LM, Nam S, Kingsbury GA, Gutierrez-Ramos JC, Coyle AJ, Kapsenberg ML, Wierenga EA. ICOS-mediated signaling regulates cytokine production by human T cells and provides a unique signal to selectively control the clonal expansion of Th2 helper cells. Eur J Immunol 2004; 34(5)1282–1290
   PubMedGoogle Scholar
• Lee WI, Zhu Q, Gambineri E, Jin Y, Welcher AA, Ochs HD. Inducible costimulator molecule, a candidate gene for defective isotype switching, is normal in patients with hyper-IgM syndrome of unknown molecular diagnosis. J Allergy Clin Immunol 2003; 112(5)958–964
   PubMedGoogle Scholar
• Kashizuka H, Sho M, Nomi T, Ikeda N, Kuzumoto Y, Akashi S, Tsurui Y, Mizuno T, Kanehiro H, Yagita H, Nakajima Y, Sayegh MH. Role of the ICOS-B7h costimulatory pathway in the pathophysiology of chronic allograft rejection. Transplantation 2005; 79(9)1045–1050
   PubMedGoogle Scholar
• Dong C, Juedes AE, Temann UA, Shresta S, Allison JP, Ruddle NH, Flavell RA. ICOS costimulatory receptor is essential for T-cell activation and function. Nature 2001; 409(6816)97–101
   PubMed Web of Science ®Google Scholar
• Zheng Y, Jost M, Gaughan JP, Class R, Coyle AJ, Monestier M. ICOS-B7 homologous protein interactions are necessary for mercury-induced autoimmunity. J Immunol 2005; 174(5)3117–3121
   PubMedGoogle Scholar
• Shi CX, Hitt M, Ng P, Graham FL. Superior tissue-specific expression from tyrosinase and prostate-specific antigen promoters/enhancers in helper-dependent compared with first-generation adenoviral vectors. Hum Gene Ther 2002; 13(2)211–224
   PubMedGoogle Scholar